← SynDRA
VORINOSTAT
SynDRA canonical compound SYN0000606 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Primary target(s) | HDAC3 |
|---|
| Mechanism of action | HDAC inhibitor |
|---|
| Indication | cutaneous T-cell lymphoma (CTCL) |
|---|
| Disease area | hematologic malignancy |
|---|
All known targets
- HDAC1
- HDAC2
- HDAC3
- HDAC6
- HDAC8
- HDAC9
- HDAC10
- HDAC11
- HDAC5
- Lta4h
- hdaH
- hda106
Mechanisms of action (all sources)
- histone deacetylase inhibitor
- HDAC1 INHIBITOR
- Histone deacetylase 1 inhibitor
- HDAC3 INHIBITOR
- Histone deacetylase 3 inhibitor
- HDAC6 INHIBITOR
- Histone deacetylase 6 inhibitor
- HDAC2 INHIBITOR
- Histone deacetylase 2 inhibitor
- HDAC10 INHIBITOR
- HDAC11 INHIBITOR
- HDAC5 INHIBITOR
Drug classes
- Histone Deacetylase Inhibitors
- Histone Deacetylase Inhibitor
- Antineoplastic Agents
- Enzyme Inhibitors
ATC classes
- L01X · OTHER ANTINEOPLASTIC AGENTS
Cross-references
Synonyms
- suberoylanilide hydroxamic acid
- Suberoylanilide hydroxamic acid
- MK-0683
- MK0683
- NSC-701852
- NSC-748799
- NSC-759852
- Zolinza
- NHNPODA
- SAHA
- SHH
- Merck brand of Vorinostat
- OCTANEDIOIC ACID HYDROXYAMIDE PHENYLAMIDE
- SAHA cpd
- Suberanilohydroxamic acid
- Vorinostat MSD
- Vorinostat [USAN]
- M344
- SKI390
- WIN64652
- SAHA, Suberoylanilide hydroxamic acid
- SW-064652
- Zolinza (TN)
- Vorinostat (JAN/USAN)
- N1-hydroxy-N8-phenyloctanediamide
- Zolinza, MK-0683, SAHA
- N'-hydroxy-N-phenyloctanediamide
- N-Hydroxy-N'-phenyl octanediamide
- N-Hyrdroxy-N'-phenyloctanediamide
- N-hydroxy-N'-phenyloctanediamide
- N-hydroxy-N'-phenyl-octane-1,8-diotic acid diamide
- Vorinostat (HDAC inhibitor)
- MK 0683
- Octanediamide, N-hydroxy-N'-phenyl-
- Vorinostat (SAHA, MK0683)
- Vorinostat (SAHA)
- CCRIS 8456
- NSC 701852
Look up VORINOSTAT in the interactive SynDRA portal →